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1. Introduction 
Narciclasme is an alkaloid of known chemical struc- 
ture and antitumour activity obtained from bulbs of 
different species of Narcissus [1-3]. In preliminary 
studies we have observed that narciclasine inhibits 
growth of cells of Ehrlich ascites tumour by immediately 
halting protein synthesis (unpublished results). This 
effect results from specific inhibition of the step of 
peptide bond formation [4], The results presented in
this paper show that resistance to narciclasine in a 
mutant strain of Saccharomyces cerevisiae is due to 
an alteration on the peptidyl transferase c ntre of the 
60S ribosomal subunit. 
2. Materials and methods 
Wild type haploid S. cerevisiae strain Y166 and the 
spontaneous TRI mutant resistant to trichodermin 
and anisomycin have been described elsewhere [5]. 
Uptake of [3 H] leucine into protein by intact cells 
was studied as previously reported [6]. 
Yeast polysomes, high salt washed ribosomes, 60S 
and 40S ribosomal subunits and the partially purified 
supernatant fraction containing elongation factors 
EF 1 and EF 2 were prepared as described elsewhere 
[5]. Poly(U)- and endogenous mRNA-directed 
[14C] phenylalanine incorporation i to 5% triclUoro- 
acetic acid precipitable polypeptides was studied ha 
ribosomal and polysomal systems, respectively [5]. 
Peptide bond formation was studied in the puromy- 
tin and the fragment reaction assays. In the puromycin 
reaction 50/,d volumes containing 50 mM Tris-HC1 
buffer, pH 7.4, 12.5 mM MgC12, 80 mM KC1, 0.5 mM 
GTP, 2 ~ of the supernatant fraction and 2.4 A2eo 
units of yeast polysomes, were incubated for 7 rain at 
30°C to allow translocation of the peptidyl-tRNA 
from the acceptor to the donor site. Various concen- 
trations of narciclasine were then added and incuba- 
tion was continued for 2 min. Two pmol [3 H] puro- 
mycin (3.7 Ci/mmol) were subsequently added and, 
after a further incubation for 1 min at 30°C, peptidyl- 
[3 H] puromycin formation was stopped by addition 
of 1 ml 10% trichloroacetic a id; the peptidyl-[3 H]- 
puromycin formed was retained on glass filters 
(Whatman GF/C) and radioactivity estimated in a 
scintillation spectrometer. The 'fragment reaction 
assay' was carried out with yeast ribosomes using 
UACCA-[3 H] Leu-Ac (52 Ci/mmol) and 1 mM puro- 
mycin as previously described [7]. 
Binding of [3H] anisomycin (285 mCi/mmol) to 
high salt washed ribosomes was studied at 0°C follow- 
hag a sedimentation method [8] in 100/~1 reaction 
mixtures containing 50 mM Tris-HC1 buffer, pH 7.4, 
12.5 mM MgC12, 80 mM KC1 and 0.1 mM dithiothrei- 
tol  [8]. Under the [3 H] anisomycin concentrations 
and experimental conditions used only the higher 
aft'mity binding of the antibiotic was observed [8]. 
is H] Anisomycin was a gift from Dr M. Barbacid 
[8]. Sources of other materials are described elsewhere 
[4,5]. 
3. Results 
3.1. Effect of  narciclasine on the uptake of[al l] 
leucine by S. cerevisiae Y166 and TR 1 strains 
The wild type X cerevisiae strain Y166 is sensitive 
to the antibiotics trichodermin and anisomycin where- 
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Fig.1. Uptake of [3H] leucine by Y166 and TR~ strains of 
Saccharomyces revisiae and the effect of narciclasine. Yeast 
cells were incubated in yeast nitrogen base-dehydrated medium 
(Difco). At the required times 100 ul samples were removed 
into 100/A ice cold 10% trichloroacetic a id and [3 H] leucine 
incorporation i to the protein fraction was determined as
described elsewhere [6]. The arrows indicate the time of 
addition of narciclasine. (A) Y166 cells; (B) TRj cells; (o) 
controls without addition of narcictasine; (m) + 5 × 10 -s M 
narciclasine; (A) + 1.5 x 10 -4 M narciclasine. 
as the TRI mutant is resistant to both antibiotics [5]. 
The alkaloid narciclasine inhibits peptide bond for- 
mation in eukaryotic ells similarly to trichodermin 
and anisomycin but the alkaloid and these two anti- 
biotics considerably differ in their chemical structure 
[4,5]. It was therefore of interest o study compara- 
tively the effect of narciclasine on both strains of 
S. cerevisiae. Narciclasine inhibits the incorPoration of 
[3H]leucine into the protein fraction of wild type 
cells, while similar concentrations of the alkaloid do 
not halt the uptake of the labelled amino acid 
by trichodermin-resistant cells (fig. 1). These results 
show that mutation to trichodermin resistance also 
induces cross resistance to narciclasine. 
3.2. The effect of  narciclasine on polypeptide 
synthesis by cell-free systems from Y166 and 
TR ~ 
Polypeptide synthesis by ribosomes or polysomes 
derived from the mutant strain TR1 is less affected by 
the presence of narciclasine than those obtained from 
wild type cells (fig.2) irrespective of the source of the 
supernatant added to the system (results not shown). 
These results uggest that resistance to narciclasine is
induced by an alteration in the mutant ribosomes. In 
order to locate the resistance to narciclasine within 
the ribosomal structure we have studied the effects of 
the alkaloid in hybrid ribosomes reassociated from 
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Fib 2. Yeast ribosomes endogenous m-RNA-directed poly- 
peptide and poly(U)-directed polyphenylalanine synthesis. 
Reactions were carried out as described under Materials and 
methods. Polyphenylalanine synthesis by ribosomal systems 
( - - ) ;  polypeptide synthesis by polysomes (---). Y166 
extracts (e); TR, extracts (o). Incorporation i  the controls 
in the absence of narciclasine was 17.3 or 470 (Y 166 
extracts) and 15.6 or 463 (TR 1 extracts) pmol of [14C]- 
phenylalanine for endogenous m-RNA- or poly(U)-directed 
poly-peptide synthesis, respectively. 
subunits of the wild type and mutant strains. The 
source of the 40S subunit was practically irrelevant 
in the extent of the inhibition by narciclasine (table 1). 
Therefore the mutation leading to resistance is
expressed in the 60S subunit. 
3.3. The effect of narciclasine on peptide bond 
formation by ribosomes and polysomes from 
Y166 and TR ~ strains 
Since narciclasine is an inhibitor of the peptidyl 
transferase centre of the larger ribosome subunit [4] 
the resistant character should be apparent at the level 
of peptide bond formation. Therefore we have studied 
the effect of narciclasine on peptidyl- [3 H] puromycin 
and Ac- [3 HI Phe-puromycin formation by polysomes 
and ribosomes from the wild type and the mutant 
strains (table 2). Indeed peptide bond formation occurs 
in the presence of narciclasine with polysomal and 
ribosomal systems from the TRl mutant. 
3.4. Effect o f  narciclasine on [3HI anisomycin 
binding to yeast ribosomes from the Y166 
and TR 1 strains 
We have studied the effects of narciclasine on [~H] - 
anisomycin to ribosomes from Y166 and TR1 to 
characterize more precisely the alterations induced in 
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Table 1 
The effect of narciclasine on poly(U)-directed polyphenylalanine 
synthesis by ribosomes reassociated from ribosomal subunits 
Subunits 
60S 40S 
[ ~ 4 C] Phenylalanine incorporated per reaction 
mixture (pmol) 
Control without + Narciclasine 
drug 
2X 10-SM 2X 10-4M 
Sensitive Sensitive 98.5 (100) 15.6 (16) 5.9 (6) 
Resistant Resistant 78.8 (100) 59.6 (76) 39.1 (50) 
Resistant Sensitive 92.9 (100) 45.4 (49) 45.0 (48) 
Sensitive Resistant 92.9 (100) 26.5 (28) 6.3 (7) 
50 t~l reaction mixtures contained 0.8 A26 o units of 60S subunits and 0.4 A26 o 
units of 40S subunits. Incorporation took place for 10 min at 30°C. Values in 
brackets represent the percentage ofcontrols. Other d.etails as described in 
Materials and methods. 
July 1975 
the peptidyl transferase centre since anisomycin binds 
with similar affinities to ribosomes from both the 
resistant and the sensitive strains [5]. Narciclasine 
inhibits to a lesser extent he binding of [3 HI aniso- 
mycin to ribosomes of the mutant strain (fig.3). This 
result suggests that resistance to narciclasine in TR~ 
cells is due, at least partially, to a lower affinity of the 
alkaloid for the mutant ribosomes, as it has been pre- 
viously shown for trichodermin [5]. However there 
are other possibilities to explain this result; thus the 
alteration in the peptidyl transferase centre in mutant 
ribosomes might diminish the inhibitory effect of 
narciclasine on [3 H] anisomycin binding without 
affecting the affinity of the alkaloid for the ribosome. 
4. Discussion 
The results presented in this contribution show that 
resistance to narciclasine in our mutant is a property 
of the 60S ribosomal subunit. The resistant TR~ strain 
used in this paper has been previously shown to bear 
a ribosomal alteration in the peptidyl transferase cen- 
ter [5]. This alteration results in a conformational 
Table 2 
Effect of narciclasine on peptide bond formation by yeast polysomes and ribosomes 
Polysomes or Peptidyl- [ 3 H] puromycin reacted Ac-[ 3 H] Leu-puromycin formation 
ribosomes (pmol) (fmol) 
Control + Narciclasine Control + Narciclasine 
without without 
drug 10 -6 M 10 -s M drug 10 -7 M 10 -6 M 
Y166 (sensitive) 1.58 (100) 0.92 (58) 0.08 (5) 1.39 (100) 0.70 (51) 0.07 (5) 
TR 1 (resistant) 1.65 (100) 1.63 (99) 0.50 (30) 0.70 (100) 0.68 (97) 0.33 (48) 
The reactions were carried out as described in Materials and methods. Polysomes and ribosomes were 
used to study peptidyl-[ 3H] puromycin and Ac-[3 H] Leu-puromycin formation respectively. Values 
in brackets represent the percentage ofcontrols. 
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Fig.3. Inhibition of [a H] aniso mycm mnmng to yeast sensi- 
tive and resistant ribosomes by narciclasine. Data were 
obtained from sedi/nentation assays as described inMaterials 
and Methods. [3H] anisomycin and ribosome concentrations 
were 1 and 3 #M respectively. The percentage of [3HI aniso- 
mycin bound to Y166 and TR t n~oosomes were 38 and 37% 
respectively. (o) Y166 ribosomes; (o) TR 1 ribosomes. 
the mutant strain is twice higher than in the case of 
using ribosomes from the wild type (fig.3). This 
result suggests that resistance to narciclasine is, at 
least partially, due to a reduced binding affinity for 
the mutant ribosomes. Other factors uch as structural 
and/or conformational lterations in the mutant ribo- 
somes rendering less effective the binding of the drug 
could also contribute to the resistance. 
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and/or structural change which has pleiotropic effects 
and induces cross resistance to trichodermin and to 
anisomycin [5]. The same mutation also induces resis- 
tance to narclclasine at the level of the peptidyl trans- 
ferase center (table 2 and fig.3). We have previously 
shown that the resistance of the TRI strain to tricho- 
derrnin and anisomycin was the effect of a single 
nuclear mutation since resistance and sensitivity to 
trichodermin and anisomycin segregated 2:2 in six 
tetrads obtained from the esporulation of a +/TRI 
diploid [5]. An identical pattern of resistance and 
sensitivity towards narciclasine has been obtained 
with cell-free xtracts from the offsprings of those 
spores (results not shown). 
The concentration of narciclasine required to inhi- 
bit by 5[3% [all] anisomycin binding to ribosomes of 
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